Podcast TCTMD Talking Points FAME 2: 3-Year Clinical and Cost-Effectiveness Outcomes of FFR-Guided PCI in Patients With Coronary Artery Disease September 05, 2018
News Conference News ESC 2018 New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All Michael O'Riordan August 29, 2018
News Daily News ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights Michael O'Riordan July 10, 2018
News Conference News EuroPCR 2018 Modest Benefit of PCI Over Medical Therapy in Patients With ‘Grey Zone’ FFR Lesions Michael O'Riordan May 23, 2018
Presentation EuroPCR 2018 Five-year Outcomes with PCI Guided by Fractional Flow Reserve in Patients with Stable Coronary Artery Disease (FAME 2) Presenter: Panagiotis Xaplanteris May 23, 2018
News Conference News EuroPCR 2018 New ORBITA Insights: Invasive Physiology Tests Track Closely With Ischemia, but Not Symptom Improvement Shelley Wood May 22, 2018
News Conference News EuroPCR 2018 FFR in PCI for Stable CAD: Lasting Benefit Shown by FAME 2, SCAAR Data Caitlin E. Cox May 22, 2018
Presentation EuroPCR 2018 ORBITA: A Physiology-stratified Analysis of the Impact of FFR and iFR on Efficacy of Coronary Angioplasty in Stable Coronary Artery Disease Presenter: Rasha Al-Lamee May 22, 2018
News Conference News EuroPCR 2018 FFR-Guided PCI Reduces Risk of Death/MI Compared With Medical Therapy: Pooled Analysis Michael O'Riordan May 22, 2018
News Daily News iFR Pullback Provides Roadmap for CAD Severity, Predicts Hemodynamics Post-PCI Caitlin E. Cox April 17, 2018
News Daily News Routine Use of FFR, iFR Changes Treatment Plans, Even in Patients With Multivessel Disease Todd Neale February 21, 2018